DiaSorin Ltd. are the prime provider in terms of complimentary solution supply within the pathology managed service arena. Offering the most comprehensive immunoassay portfolio, DiaSorin currently have 72 LIAISON®XL placements in the UK and Ireland.
The Liaison®XL offers a multidisciplinary portfolio of over 110 assays including a highly regarded ID panel. The LIAISON® QuantiFERON®-TB Gold Plus assay is the most recent addition to the portfolio. Also having recently identified an un-met need for total automation within stool testing and we now facilitate stool testing on the LIAISON®XL platform alongside serology testing thus consolidating and improving the efficiency of the laboratory.
Sponsors & Exhibitors
As a world leader in the in-vitro diagnostics industry boasting over 35 years’ experience, Randox products offer clinicians and physicians the most comprehensive insight into patient diagnosis, facilitating the best possible disease management and treatment. Randox believe that tomorrows healthcare depends on innovations developed today so are advancing cutting edge technologies that hold key ground-breaking improvements in diagnostics and healthcare. From diagnostic reagents to world leading quality control solutions, forensic toxicology to food diagnostics, workplace drugs testing to our RX series Clinical Chemistry Analysers, the vision of Randox is one of ambition, innovation and commitment to improving health worldwide.
“EUROIMMUN UK supplies the healthcare industry with medical diagnostic products in the following principal areas: Autoimmunity, Infectious Serology and Allergy.
EUROIMMUN UK is the British subsidiary of the EUROIMMUN Group, which is one of the world’s leading manufacturers of medical laboratory diagnostic products. Detection methods innovated by EUROIMMUN include indirect immunofluorescence, ELISA, immunoblots (Western blot, EUROASSAY, EUROLINE, EUROLINE-WB) and molecular diagnostics (EUROArray).
Diagnostic test systems are offered alongside fully automated instruments and IT solutions. Coupled with the International Training Centre, Reference Laboratory and Institute for Quality Assurance, EUROIMMUN is proud to offer exemplary service and support.”
"Fujifilm’s new IMMUNO AG2 analyser is an innovative, rapid diagnostic test system for influenza A and B, RSV and adenoviruses. Full connectivity and a built-in barcode reader offer easy operation, automatic determination and automatically printed results, all of which prevent determination errors that are common with visual inspection. The highly sensitive detection technology uses the silver amplification principle of photographic development, which provides accurate detection of even a small amount of antigen during the early stages of ‘flu. With a sleek, compact design, simple touch screen panel and combined light and sound notification signals, the IMMUNO AG2 is the next generation of infection detection."
Eurogentec is an international company founded in 1985 and part of Kaneka Corp. since 2010.
Headquartered in Liege (Belgium) it provides products and services to scientists involved in the life science research, molecular diagnostics and therapeutic developments.
Eurogentec has production sites in Europe and United States of America.
The company is recognized as one of the major suppliers in the field of genomics and proteomics as well as a trusted US FDA inspected Contract Development and Manufacturing Organization (CDMO) for the bio-production of pharmaceuticals (vaccines and medicines).
Expert in small and large-scale synthesis, Eurogentec produces a wide range of custom oligos from classical primers up to highly complex sequences.
HORIBA Medical is a renowned specialist in the design and manufacture of automated in vitro diagnostic systems for haematology for over 30 years, and chemistry focused analytical solutions for over 15 years. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management solutions to meet all needs, enabling analysis anywhere it is required. Further to this, HORIBA UK Ltd is committed to developing local and international partnerships in order to develop solutions to support our customers and their specific requirements.
Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics with our first system and we’ve never looked back. And now, even with the largest installed base of any molecular platform, Cepheid is constantly innovating and evolving our capabilities. Our technology has been heralded as game-changing by healthcare leaders world-wide. We envision a better way for clinical institutions of any size, from small medical clinics to high-volume reference laboratories and major hospitals, to access the power of molecular diagnostics. Our GeneXpert® System delivers fast, scalable, and accurate diagnostic results while our expanding Xpert® test menu spans multiple clinical applications such as healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology. Make a difference in healthcare and join us on this mission! For more details, please visit us at www.cepheid.com.
The Native Antigen Company specialises in the development of both native and recombinant antigens, antibodies and immunoassays for infectious disease. Our antigens are used by leading pharmaceutical companies and IVD manufacturers in cutting-edge vaccine research and serology where proper folding and glycosylation are vital. Our rapidly expanding portfolio also includes highly specific antibodies and immunoassays. Our expertise is available to customers on a contract basis for custom protein manufacture and antibody and immunoassay development.